Phreesia, Inc. PHR
Phreesia, Inc. ("Phreesia," "we," "our," or the "Company") was founded in 2005 and completed its initial public offering in July 2019. Phreesia provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Our platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum.
We serve a diverse group of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Our solutions support the patient journey from care discovery and scheduling through intake, payment, and post-visit follow-up. In fiscal year 2026, our platform facilitated approximately 180 million patient visits, representing approximately one in six ambulatory patient visits in the United States.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $467.8M | $410.5M | $346.0M | $280.9M | $213.2M | $148.7M | $124.8M | $99.9M | $79.8M | — |
| R&D | $121.5M | $117.4M | $112.3M | $91.2M | $52.3M | $22.6M | $18.6M | $14.3M | $11.4M | — |
| SG&A | $79.9M | $76.6M | $79.9M | $80.4M | $68.7M | $40.5M | $30.5M | $20.1M | $18.8M | — |
| Total operating expenses | $487.2M | $477.9M | $492.8M | $457.5M | $330.1M | $174.3M | $140.1M | $109.4M | $94.4M | — |
| Operating income | -$6.6M | -$58.1M | -$136.5M | -$176.6M | -$116.8M | -$25.7M | -$15.3M | -$9.5M | -$14.6M | — |
| Interest expense | $7.0M | $2.3M | $1.9M | $1.4M | $1.2M | $1.7M | $3.0M | $3.5M | $3.6M | — |
| Pre-tax income | -$8.9M | -$55.8M | -$135.3M | -$175.7M | -$118.0M | -$27.2M | -$22.1M | -$15.1M | -$18.2M | — |
| Income tax | $11.2M | $2.7M | $1.5M | $483.0K | $182.0K | $49.0K | $1.8M | $0 | $0 | — |
| Net income | $2.3M | -$58.5M | -$136.9M | -$176.1M | -$118.2M | -$27.3M | -$20.3M | -$15.1M | -$18.2M | — |
| EPS, basic | 0.04 | -1.02 | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 | — | — | — |
| EPS, diluted | 0.04 | -1.02 | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 | -24.53 | -24.81 | — |
| Shares, diluted (wtd. avg.) | 61.5M | 57.6M | 54.6M | 52.4M | 49.9M | 39.5M | 20.3M | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $73.8M | $84.2M | $87.5M | $176.7M | $313.8M | $218.8M | $90.3M | $1.5M | $10.5M | $2.3M |
| Receivables | $97.5M | $73.6M | $64.9M | $51.4M | $40.3M | $29.1M | $22.0M | $16.1M | — | — |
| Total current assets | $279.8M | $203.3M | $195.7M | $262.4M | $386.3M | $272.3M | $131.5M | $33.3M | — | — |
| Property, plant and equipment | — | — | — | — | — | $26.7M | $14.5M | $14.2M | — | — |
| Goodwill | $170.1M | $75.8M | $75.8M | $33.7M | $33.6M | $8.3M | $250.0K | $250.0K | — | — |
| Other intangibles | $79.8M | $28.1M | $31.6M | $11.4M | $12.8M | $2.7M | $1.2M | $1.4M | — | — |
| Total assets | $663.8M | $388.4M | $370.3M | $370.1M | $494.5M | $326.7M | $158.8M | $59.3M | — | — |
| Accounts payable | $11.5M | $5.6M | $8.5M | $10.8M | $5.1M | $4.4M | $6.0M | $3.8M | — | — |
| Short-term debt | — | — | — | — | — | — | $0 | $97.0K | — | — |
| Total current liabilities | $183.2M | $114.0M | $110.1M | $79.0M | $68.4M | $55.0M | $35.4M | $27.9M | — | — |
| Long-term debt | $2.7M | $1.9M | $3.1M | $246.0K | $360.0K | $1.6M | $19.4M | $27.9M | — | — |
| Total liabilities | $326.6M | $123.6M | $118.9M | $82.2M | $77.2M | $63.4M | $56.9M | $63.7M | — | — |
| Retained earnings | -$799.2M | -$801.5M | -$743.0M | -$606.1M | -$429.9M | -$311.8M | -$284.5M | -$211.0M | — | — |
| Total equity | $337.2M | $264.8M | $251.4M | $287.8M | $417.3M | $263.3M | $101.9M | -$211.0M | -$167.7M | -$130.5M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $78.8M | $32.4M | -$32.4M | -$90.1M | -$74.7M | $2.9M | $826.0K | -$2.1M | -$11.1M | — |
| Depreciation and amortisation | $31.5M | $27.9M | $29.5M | $25.3M | $21.3M | $15.9M | $13.9M | $11.6M | $9.6M | — |
| Stock-based compensation | $67.5M | $67.0M | $71.6M | $58.8M | $36.1M | $13.5M | $6.2M | $1.4M | $805.0K | — |
| Capital expenditure | $11.1M | $8.7M | $5.8M | $4.7M | $18.4M | $11.2M | $7.0M | $4.7M | $6.6M | — |
| Investing cash flow | -$161.9M | -$24.1M | -$39.7M | -$26.2M | -$65.2M | -$25.1M | -$12.3M | -$11.0M | -$12.0M | — |
| Financing cash flow | $72.9M | -$11.5M | -$17.1M | -$20.8M | $235.0M | $150.7M | $100.3M | $4.2M | $31.3M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001412408-26-000155.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $79.8M | $99.9M | $124.8M | $148.7M | $213.2M | $280.9M | $346.0M | $410.5M | $467.8M |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | — | -$18.2M | -$15.1M | -$20.3M | -$27.3M | -$118.2M | -$176.1M | -$136.9M | -$58.5M | $2.3M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Results announced Item 2.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Material agreement signed Item 1.01
- Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
- New debt or obligation Item 2.03
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7389
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MA | Mastercard Inc | $541.11B | 37.1x | 16.4% |
| ACN | Accenture plc | $151.36B | 20.3x | 7.4% |
| UBER | Uber Technologies, Inc | $135.07B | 14.0x | 18.3% |
| MELI | MERCADOLIBRE INC | $84.60B | 42.4x | 34.3% |
| DASH | DoorDash, Inc. | $73.17B | 79.1x | 27.9% |
| EBAY | EBAY INC | $52.79B | 27.3x | 7.9% |
| PYPL | PayPal Holdings, Inc. | $48.51B | 10.2x | 4.3% |
| MSCI | MSCI Inc. | $44.90B | 39.4x | 9.7% |